Drug
Nn3201
Nn3201: highest development phase Phase 1, developed by Novelty Nobility, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Novelty Nobility, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| NN3201 NCT06805825 | Phase 1 | Gastrointestinal Stromal Tumors |
Latest
No recent events.
Follow Nn3201 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.